drugset / Trial / NCT06120036

Dosing and Tolerability of Deoxycholic Acid vs. Polidocanol in the Treatment of Neurofibromatosis Type 1 Cutaneous Neurofibromas

NCT06120036

RandomizedParallel-groupOpen-labelOther

Summary

This study will evaluate the tolerability and effectiveness of two treatments in Neurofibromatosis Type 1 Cutaneous Neurofibromas. These treatments are: Kybella and Asclera injection. Each patient will have a treatment and a control site.

Timeline

Start
2022-12-06
Primary completion
2025-01-09
Completion
2025-01-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator ATX-101 Peptide
Comparator Polidocanol Other / unclassified